News
January 23, 2025
3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused private equity firm committed to driving transformative growth for lower middle-market businesses, is proud to announce the appointment of Martin LeBlanc as chairman of its Strategic & Operational Advisory Board.
Learn moreDecember 5, 2024
Enjoin, LLC ("Enjoin" or the "Company") is pleased to announce that experienced healthcare leader Steve Hynes has joined its Board of Directors (the "Board") as executive chairman.
Learn moreNovember 21, 2024
3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused, lower middle-market private equity firm, announces a majority growth investment in Enjoin, LLC ("Enjoin" or the "Company"), a leader in Clinical Documentation Integrity ("CDI") solutions for hospitals and health systems nationwide.
Learn moreJune 24, 2024
3 Boomerang Capital has announced a strategic growth investment in Analytical Biological Services Inc. (ABS), marking the first platform investment of its newly closed Fund I.
Learn moreFebruary 6, 2024
3 Boomerang Capital Raises Over $375 Million for Healthcare Private Equity Fund, Exceeding Target
Learn more